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REPORT
Haploinsufﬁciency of TCF4 Causes Syndromal Mental Retardation
with Intermittent Hyperventilation (Pitt-Hopkins Syndrome)
Christiane Zweier, Maarit M. Peippo, Juliane Hoyer, Se´rgio Sousa, Armand Bottani,
Jill Clayton-Smith, William Reardon, Jorge Saraiva, Alexandra Cabral, Ina Go¨hring, Koen Devriendt,
Thomy de Ravel, Emilia K. Bijlsma, Raoul C. M. Hennekam, Alfredo Orrico, Monika Cohen,
Alexander Dreweke, Andre´ Reis, Peter Nu¨rnberg, and Anita Rauch
Pitt-Hopkins syndrome is a rarely reported syndrome of so-far-unknown etiology characterized by mental retardation,
wide mouth, and intermittent hyperventilation. By molecular karyotyping with GeneChip Human Mapping 100K SNP
arrays, we detected a 1.2-Mb deletion on 18q21.2 in one patient. Sequencing of the TCF4 transcription factor gene, which
is contained in the deletion region, in 30 patients with signiﬁcant phenotypic overlap revealed heterozygous stop, splice,
and missense mutations in ﬁve further patients with severe mental retardation and remarkable facial resemblance. Thus,
we establish the Pitt-Hopkins syndrome as a distinct but probably heterogeneous entity caused by autosomal dominant
de novomutations in TCF4. Because of its phenotypic overlap, Pitt-Hopkins syndrome evolves as an important differential
diagnosis to Angelman and Rett syndromes. Both null and missense mutations impaired the interaction of TCF4 with
ASCL1 from the PHOX-RET pathway in transactivating an E box–containing reporter construct; therefore, hyperventi-
lation and Hirschsprung disease in patients with Pitt-Hopkins syndrome might be explained by altered development of
noradrenergic derivatives.
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In 1978, Pitt and Hopkins described two patients with
sporadic “mental retardation, wide mouth and intermit-
tent overbreathing.”1 Since then, only four other sporadic
cases with a similar phenotype and one sib pair with pos-
sible Pitt-Hopkins syndrome (PHS) have been published,
but there is no MIM entry for this entity.2–5 Breathing ab-
normalities in these published patients with PHS appeared
inmidchildhood, were present onlywhen theywere awake,
and consisted of abrupt paroxysms of tachypnea followed
by breath holding and even overt cyanosis. Other com-
mon ﬁndings were epilepsy with severe grand mal sei-
zures, short stature, microcephaly, severe motor and men-
tal retardation, and minor brain abnormalities such as
cerebellar and vermis hypoplasia, hypoplasia of the corpus
callosum, small hippocampus, and bulging caudatenuclei.
Facial features were characterized by heavy supraorbital
regions, a broad and beaked nose with a high bridge and
ﬂaring nostrils, a wide mouth, broad palate, and a bow-
shaped upper lip.3
Since extensive metabolic studies and conventional kar-
yotyping did not reveal any clues regarding the etiology,
we performed molecular karyotyping6 using GeneChipHu-
man Mapping 100K SNP arrays (Affymetrix) in the two
sporadic cases published by Peippo et al.3 This work was
performed as part of our research study addressing the
genetics of mental retardation, which was approved by
the Research Ethics Committee of the Medical Faculty of
the University of Erlangen-Nuremberg. For molecular kar-
yotyping, DNA samples were hybridized to GeneChip Hu-
man Mapping 50K Xba240 and Hind240 arrays, and im-
ages were obtained using an Affymetrix GeneChip Scan-
ner 3000. Raw data were analyzed with the Affymetrix
copy-number analysis tool (CNAT 2.0.0.9), with 0.5-Mb
sliding windows for the genomic smoothing algorithm
(GSA). Copy-number values calculated by the CNAT were
ﬁltered for clusters of SNPs with high GSA P values with
use of a self-programmed software tool that we named
“CNVFinder” (J. Hoyer, A. Dreweke, C. Becker, I. Go¨hring,
C. Thiel, M. M. Peippo, R. Rauch, M. Hofbeck, U. Traut-
mann, C. Zweier, M. Zenker, U. Hu¨ffmeier, C. Kraus, A.
Ekici, F. Ru¨schendorf, P. Nu¨rnberg, A. Reis, and A. Rauch,
unpublished material). In one of the two patients an-
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Figure 1. Results of molecular karyotyping with Affymetrix GeneChip Human Mapping 100K SNP array in patient 2. A, Plot oflog10
GSA P values for SNPs covering chromosome 18, with use of a Gnuplot program. The 1.2-Mb deletion in 18q21.2 is visible through a
cluster of SNPs with GSA P values !2.5. The 63 SNPs indicating a deletion are ﬂanked by SNP_A-1695165 (rs4800947; 50,552,638
Mb) and SNP_A-1724163 (rs784395; 51,742,365 Mb). Genotypes of individual SNPs are indicated by colored bars at the bottom
(magentaphomozygous; bluepheterozygous; brownpno call). Note the magenta stretch of homozygosity corresponding to the deleted
region. B, Representative results of two-color FISH analyses, with the RP11-7L24 probe labeled with Cy3 (pink) in combination with a
FluoroX-labeled (green) subtelomeric 18p control probe, for patient 2 and his parents. Whereas the RP11-7L24 probe is lacking on one
chromosome 18 homologue in the patient, it is present on both homologues in the parents, demonstrating de novo origin of the
deletion in patient 2.
alyzed, molecular karyotyping revealed a 1.2-Mb dele-
tion on 18q21.2 (ﬁg. 1A). The deletion was conﬁrmed by
FISH analysis with 18q21.2 BACs RP11-99A1 (RAB27B;
50.5–50.7 Mb), RP11-839G9 (CCDC68; 50.7–50.9 Mb),
and RP11-7L24 (TCF4 [GenBank accession number NM_
003199.1]; 51.1–51.24Mb), all of which lacked the speciﬁc
signal on one chromosome 18 homologue (GenBank ac-
cession number NT_025028.13) (ﬁg. 1B). All three BACs
gave normal FISH results in both parents, thus conﬁrming
de novo origin of the deletion in the patient. This deletion
contained three known genes: RAB27B (a member of the
RAS oncogene family), CCDC68 (coiled-coil domain con-
taining 68), and TCF4 (transcription factor 4). Since, ac-
cording to the UCSC Genome Browser database, only
TCF4 is highly expressed in fetal and adult brain, we con-
sidered it the most likely candidate gene for the PHS phe-
notype. Sequence analysis of coding exons 2–19 and in-
tronic ﬂanking regions of TCF4 in the second patient pub-
lished by Peippo et al.3 revealed the missense mutation
R576/580W within exon 18, which codes for the helix-
loop-helix (HLH) domain of TCF4. Sequencing was per-
formed bidirectionally on an ABI 3730 capillary sequencer
(Applied Biosystems) (detailed conditions and primer se-
quences are available on request). De novo origin of the
missense mutation was proven by its exclusion in both
parents. Paternity was veriﬁed, and mistake of probes was
excluded by genotyping 14 polymorphic microsatellite
markers in the child and both parents (PowerPlex 16 Sys-
tem [Promega]).
Because of phenotypic overlap with the Mowat-Wilson
syndrome (MIM 235730), both patients had been tested
for mutations in the ZFHX1B gene before this study.3,7
We therefore screened 87 patients for TCF4 mutations in
whom ZFHX1B testing had revealed normal results. None
of these patients with mental retardation and variable fea-
tures of the Mowat-Wilson syndrome spectrum, includ-
ing constipation and Hirschsprung disease (HSCR [MIM
142623]), showed a TCF4 mutation.
We then sequenced 29 further patients with a more spe-
ciﬁc phenotypic overlap with PHS—that is, with at least
two of the following features: severe mental retardation,
breathing anomalies, and PHS-like facial dysmorphism.
These patients also included a sib pair and a sporadic case
formerly published as having PHS or possible PHS.2,3,5 The
original cases published by Pitt and Hopkins1 were not
available, because one patient died and the other was lost
to follow-up (D. Pitt, personal communication). The case
published by Singh4 could not be tracked either. TCF4
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Figure 2. Schematic drawing of the 1.2-Mb deletion region in patient 2 and location and electropherograms of TCF4 mutations in
patients 1, 3, 4, 5, and 6 within a schematic drawing of exon-intron structure of TCF4. Noncoding exons are light gray, and the exon
coding for the functional domain is black. Blue bars representing BAC clones and blue squares representing SNPs indicate deletion of
respective probes, whereas nondeleted SNPs are depicted as black squares.
mutational analysis revealed three heterozygous stop mu-
tations and a splice-site mutation in four of the unpub-
lished patients (ﬁg. 2 and table 1). De novo origin was
proven in two patients (3 and 4), whereas parents of pa-
tients 5 and 6 were not available for testing. We therefore
excluded both the R385X and IVS9-1GrC mutations of
the latter patients in a total of 180 healthy European con-
trol individuals.
Since most of our patients have a deletion or stop or
splice-site mutations, haploinsufﬁciency of TCF4 is likely
to be causative of PHS. The only observed missense mu-
tation affects an evolutionarily conserved amino acid and
is located within the basic HLH (bHLH) domain of TCF4,
thus likely impairing the binding capacity of the only
functional domain known so far. TCF4 (also called “ITF2,”
“E2-2,” and “SEF2”) consists of 20 exons (exons 1 and 20
are noncoding), spans 360 kb, and encodes at least two
isoforms of the transcription factor 4 protein, differing in
the presence of 4 aa (RSRS) 17 residues before the HLH
domain. TCF4 belongs to the class A subfamily of bHLH
transcriptional regulators—also called “E proteins,” since
their basic domain binds to the E-box motifs 5′-ACANN-
TGT-3′ or 5′-CCANNTGG-3′.8 E proteins are characterized
by a broad expression pattern and the ability to form both
homo- and heterodimers with other classes of HLH pro-
teins that are tissue speciﬁc or lack the basic DNA-binding
domain.9,10
Homozygous Tcf4 deletions in mice lead to early le-
thality of unknown reason and a slight decrease in pro-B
cell numbers.10 In contrast to the apparently normal sin-
gle heterozgyous Tcf4-knockout mice, transheterozygous
knockout combinations of any two of the E proteins Tcf4,
E2a, and Heb generate signiﬁcantly reduced numbers of
pro-B cells, and mice conditionally mutated in Tcf4 show
a partial block in both B and T lymphocyte develop-
ment.9,10 Accordingly, none of our patients with hetero-
zygous TCF4 mutations showed clinical evidence of im-
munodeﬁciency, and lymphocyte and Ig counts in patient
3 showed normal results. Nevertheless, patient 6 devel-
oped a Hodgkin lymphoma at age 29 years, which might
indicate some kind of regulatory inﬂuence of TCF4 on
lymphocyte growth. The diversiﬁed phenotypes observed
with E-protein deﬁciencies are consistent with the idea
that E proteins are involved in dimeric interactions with
many different tissue-speciﬁc HLH proteins.10 Ascl1, the
mouse homologue of one of these tissue-speciﬁc proteins,
is highly expressed in speciﬁc regions of the developing
CNS and in sympathetic and enteric precursor cells, and
Ascl1-null mice die at birth.11 ASCL1 was shown to form
complexes with TCF4 that have the ability to bind an E
box.11 The interaction between TCF4 and ASCL1 is an in-
teresting observation, sincemutations inASCL1have been
shown to impair the noradrenergic neuronal development
in brain stem, causing some cases of congenital central
hypoventilation syndrome (CCHS, or Ondine curse [MIM
209880]).12 In Ascl1-knockout mice, an impaired c-RET ex-
Table 1. Clinical Findings for Patients with TCF4 Mutations
Characteristic
Finding for Patient
1a 2a 3 4 5 6
Sex M M M F M F
Age (years) 14 11 8 12 29 29
Birth:
Weight, in grams 2,800 (1P3) 2,620 (1P10) 2,520 (1P25) 2,450 (P10) 3,660 (P50) 2,500 (P3)
Length, in cm 48 (10th) 47 (P10) 49 (1P50) 46 (P3) 53? cm (!P75) NA
OFC, in cm 33 (3rd) 33 (25th) 32.5 (25th) 31.5 (10th) NA NA
Postnatal growth: NA NA Weight P75 Weight P10 Weight !P3 Weight !P3
Height 3 SD 3 SD P10–P25 P25 !P3 !P3
OFC 3 SD 5 SD P25 P25 !P3 !P3
Walking Steps with aid Steps with aid Steps with aid At age 5 years; ataxic At age 14 years; ataxic At age 7 years; wide base
Speech No No Single words No No No
Seizures At age 9 years At age 8 years No No No No
Hypotonia Yes Severe Severe Severe Yes Yes
H-A Daytime Daytime No Daytime Yes Yes
Age at onset (years) 5 6 … 8 2 5
MRI anomalies HCC, small hippocampus, and
bulging caudate nuclei
HCC, small hippocampus,
and bulging caudate nuclei
Dilated cerebral ventricles HCC and bulging caudate nuclei NA CT only; no structural abnormality
SDFC (ﬁnger[s]) No No Yes (3 and 4, BL) Yes (2, 3, and 4, BL) Yes (3 and 4, BL) Yes (4)
SPC Yes No Yes Yes Yes NA
Happy disposition Yes Yes Yes Yes Unmotivated laughter episodes Yes
Intestinal anomalies Constipation HSCR No No Severe constipation No
Other anomalies Broad ﬁnger tips and wide and
ﬂat palate
Broad ﬁnger tips and wide and
ﬂat palate
Strabismus, scoliosis, sacral dimple,
fetal ﬁnger pads, overriding 5th
toe, and short metatarsal V
Supernumerary nipple, scoliosis, and long
and slender ﬁngers and toes
Strabismus, very anxious,
autoaggressive behavior,
short hands and feet, and hyper-
convex nails
Lymphoma, fetal ﬁnger pads, slender
feet with short IV/V metatarsals,
dislocated hips, and frontal cowlick
Test result:
AS methylation NA NA Normal Normal Normal NA
UBE3A NA NA Normal Normal NA NA
TCF4 c.1726/1738CrT p.R576/580W
de novo
1.2-Mb deletion de novo c.692-694insT p.G232fsX256 de novo c.965-969delATGCT p.D322fsX336 de novo c.1153CrT p.R385X IVS9-1GrC
NOTE.—All patients have distinctive PHS facial features and severe mental retardation. Results of karyotype tests and MECP2 tests were normal for all patients. AS methylationpmethylation-sensitive PCR at the SNRPN locus concerning Angelman syndrome;
BLpbilateral; H-Apepisodes of hyperventilation-apnea; HCCphypoplasia of corpus callosum; NApnot available; SDFCpsupernumerary digital ﬂexion crease; SPCpsingle palmar crease(s); Pppercentile; OFCpoccipitofrontal circumference.
a Patients 1 and 2 were published as cases 1 and 2, respectively, by Peippo et al.3
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Figure 3. Transcriptional reporter assay showing impaired interaction of TCF4/TCF4 mutants with ASCL1. JEG-3 cells were transiently
transfected with a luciferase reporter construct with a herpes simplex thymidine kinase promoter either without binding sites (tkGL2)
or with four E boxes (4xEtkGL2) located within the pTa enhancer. Cotransfection was performed with an empty CMV-expression vector
(white) or CMV-expression vectors containing the complete cDNA of either ASCL1 (red), TCF4 (pale yellow), its splice variant TCF4
(including amino acid RSRS) (bright yellow), as well as wild-type or three different mutants of TCF4 and TCF4, transfected in combination
with ASCL1 (different shades of orange). Results were normalized for transfection efﬁciency to a cotransfected renilla luciferase vector
and were expressed as mean values with SD of three independent transfections. Probably because of endogenous E proteins, cells
transfected with the empty CMV vector alone already showed a slight transactivation of the luciferase vector containing the four E
boxes (4xEtkGL2), in comparison with the reporter vector without E boxes (tkGL2). TCF4 and TCF4 alone did not increase the activation
of the reporter construct but enhanced the observed activation by ASCL1 when cotransfected with the latter. In contrast, TCF4 and
TCF4 mutants containing the mutation p.G232fsX256, R385X, or R576/580W did not enhance the activation by ASCL1. Differences in
activation levels showed signiﬁcant P values obtained by the Student t test.
pression in brain-stem noradrenergic neurons and an in-
creased baseline breathing frequency were reported.13 The
major gene that causes CCHS, PHOX2B, also belongs to
the RET-signaling pathway, which, in mice, involves the
sequential expression of the Ascl1, Phox, Ret, and TH genes
that are responsible for the development of all transient
or permanent noradrenergic derivatives.12
To investigate this interaction between TCF4 mutants
and ASCL1, we established a transcriptional reporter assay
using a luciferase reporter construct with a herpes simplex
thymidine kinase promoter, either without binding sites
(tkGL2) or with four E boxes (4xEtkGL2) located within
the pTa enhancer, which interacts with several E pro-
teins.14 JEG-3 cells (derived fromhuman choriocarcinoma,
American-type culture collection cell line HTB-36) were
transiently cotransfected with a cytomegalovirus (CMV)–
expression vector containing ASCL1, TCF4, its splice var-
iant TCF4 (including amino acid RSRS), either alone or
in combination, and three different mutants of TCF4 and
TCF4 in combination with ASCL1 (ﬁg. 3). Results were
normalized, for transfection efﬁciency, to a cotransfected
renilla luciferase vector.
In accordance with the results observed by Persson et
al.,11 who used a transcriptional reporter construct con-
taining four E boxes from the muscle creatine kinase en-
hancer, in our assay, TCF4 and TCF4 alone did not in-
crease the activation of the reporter construct but en-
hanced the observed activation by ASCL1 when cotrans-
fected with the latter. In contrast, TCF4 and TCF4 mu-
tants containing the mutations p.G232fsX256, R385X, or
R576/580W did not enhance the activation by ASCL1 (ﬁg.
3). Therefore, breathing anomalies in patients with PHS
may also be caused by impaired noradrenergic neuronal
development through defective TCF4 interaction with the
ASCL1-PHOX-RET pathway. This interaction might also
explain the occurrence of HSCR and constipation in pa-
tients 1, 2, and 5, since RET is the major gene for isolated
HSCR15 and since patients with CCHS show an increased
incidence of HSCR (20%).16 However, no obvious defect
in the sympathetic nervous system in Tcf4-knockoutmice
was observed that could be attributed to a functional in-
teraction with Ascl1.11 In contrast to patients with CCHS,
who are intellectually not impaired, patients with PHS are
severely mentally retarded, which may indicate TCF4 in-
volvement in other pathways important for brain devel-
opment and function corresponding to its high expression
in brain.17
All six patients with TCF4 mutations showed severe
mental retardation and striking facial resemblance, at least
to patient 1 initially reported by Pitt and Hopkins,1 con-
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Figure 4. Facial phenotype of patients with TCF4 mutations. A–C, Patient 1 at ages 6 mo (A), 18 mo (B), and 14 years (C). D and H,
Patient 6 at age 29 years. E–G, Patient 2 at ages 6 mo (E and F) and 11 years (G). I–K, Patient 3 at ages 3 years (I), 6 years (J), and
8.75 years (K). L and M, Patient 4 at age 12.5 years. Note deep-set eyes; broad and beaked nasal bridge with down-turned, pointed
nasal tip and ﬂaring nostrils; wide mouth with widely spaced teeth, and Cupid-bowed upper lip and everted lower lip; mildly cup-
shaped, ﬂeshy ears; as well as increased coarsening of facial features with age.
sisting of deep-set eyes; broad and beaked nasal bridge
with down-turned, pointed nasal tip and ﬂaring nostrils;
widemouthwithwidely spaced teeth, Cupid-bowedupper
lip, and everted lower lip; and mildly cup-shaped, ﬂeshy
ears (ﬁg. 4). Further ﬁndings were variable, including
breathing abnormalities, which were not yet obvious in
patient 3 at age 8 years (table 1). Other common signs
were magnetic resonance imaging (MRI) anomalies such
as hypoplastic corpus callosum and bulging caudate nu-
clei, happy disposition or unmotivated laughter episodes,
muscular hypotonia, severe constipation or HSCR, single
palmar creases, and supernumerary digital ﬂexion creases.
The manifestation of a lymphoma in one of the oldest
patients may be attributed to the role of TCF4 in lympho-
cyte development,9,10 but further observations and TCF4
studies in lymphoma tissues are necessary to address this
question.
Since most of the patients in whom TCF4 mutations
were identiﬁed had previous testing for Angelman syn-
drome (MIM 105830) because of facial and behavioral re-
semblance and for Rett syndrome (MIM 312750) because
of late-onset ventilation anomalies and severe mental re-
tardation, PHS might be an important differential diag-
nosis for these disorders. Interestingly, one patient with
severe mental retardation and attacks of deep sighing and
hyperventilation who carries an interstitial deletion (18)-
(q21.1q22.3) was reported as a case of “atypical Rett syn-
drome.”18 In contrast, Joubert syndrome (MIM 213300,
608091, 609583, 608629, 610688, and 610188) was never
considered in any of these patients, because its character-
istic intermittent hyperventilation-apnea anomaly mani-
fests in the newborn. Although most of the patients
showed more or less overlapping features, we were unable
to demonstrate a mutation in the remaining 24 patients,
including the sporadic case published by Van Balkom et
al.5 and the sib pair described by Orrico et al.2 Although
larger gene deletions were excluded by the presence of
heterozygous SNPs in all but 2 of the 24 patients, we can-
not exclude atypical intronic mutations or single-exon de-
letions in the 24mutation-negative patients.Nevertheless,
the large number ofmutation-negative patientswithmore
or less similar phenotype might indicate the involvement
of further genes that possibly interact with TCF4.
Our study shows that molecular karyotyping6,19,20 (ge-
nomewide copy-number proﬁling) is able not only to
disclose novel microdeletion syndromes21–23—as well as
the underlying gene defect in well-known disorders, as
recently shown for the autosomal dominant CHARGE
(coloboma, heart anomaly, choanal atresia, retardation,
genital and ear anomalies) syndrome (MIM 214800)24
and the autosomal recessive Peters-Plus syndrome (MIM
261540)25—but also to resolve the etiology in very rarely
reported phenotypes. However, our ﬁndings suggest that
PHS is widely underdiagnosed, just as the now clinically
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recognizable Mowat-Wilson syndrome was until the iden-
tiﬁcation of the underlying gene defect, in 2001.7,26,27 No-
tably, PHS is, to our knowledge, the ﬁrst constitutive phe-
notype in which the etiology was identiﬁed by molecular
karyotyping with use of genomewide SNP arrays.
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